Neogen Corporation NEOG

Company Overview

Neogen Corporation (NASDAQ: NEOG) is a U.S.-based food and animal safety company that develops and markets products and services focused on food quality, animal health, genomics, and biosecurity. The company operates primarily within the food safety, livestock, companion animal, and agricultural testing industries. Neogen’s core offerings include diagnostic test kits, pathogen detection systems, veterinary instruments, genomic testing services, disinfectants, rodenticides, and animal health products used by food producers, processors, laboratories, veterinarians, and agricultural operators.

The company’s primary revenue drivers are its Food Safety and Animal Safety businesses, which expanded significantly following the combination of Neogen and the former 3M Food Safety business in 2022. Neogen serves customers across the food production chain, including meat and poultry processors, dairy producers, grain operators, retailers, and animal breeders. Its strategic positioning is built around integrated food and animal safety solutions, a broad recurring consumables portfolio, and long-term customer relationships supported by regulatory and quality compliance needs. Founded in 1982 and headquartered in Lansing, Michigan, Neogen evolved from a specialized diagnostics provider into a diversified global testing and biosecurity company through organic growth and acquisitions.

Business Operations

Neogen organizes operations primarily through the Food Safety and Animal Safety segments. The Food Safety business includes pathogen and allergen detection systems, sanitation monitoring, genomic testing, culture media, and laboratory services used throughout food manufacturing and agricultural supply chains. The integration of the former 3M Food Safety business materially expanded Neogen’s technology portfolio, including molecular detection systems and indicator testing products. The Animal Safety segment includes veterinary instruments, biosecurity products, animal care products, genomic services, and reproductive and herd-management tools for livestock and companion animals.

The company generates revenue through product sales, recurring consumables, testing services, and genomics-related offerings. Neogen maintains operations across North America, Europe, Latin America, and Asia-Pacific, supported by manufacturing facilities, laboratories, and commercial offices. Key assets include proprietary diagnostic technologies, genomics databases, and bioinformatics capabilities. Subsidiaries and acquired businesses that have contributed to operational expansion include Geneseek, Megazyme, and the former 3M Food Safety assets. The company also maintains strategic relationships with food processors, agricultural producers, and laboratory networks globally.

Strategic Position & Investments

Neogen’s strategic direction has focused on expanding its end-to-end food and animal safety ecosystem through acquisitions, molecular diagnostics, genomics, and digital analytics capabilities. A major milestone was the 2022 combination with the former 3M Food Safety business, which significantly expanded Neogen’s scale, international reach, and testing technology portfolio. The transaction created a broader integrated diagnostics platform across food pathogen detection, environmental monitoring, and quality assurance testing.

The company continues investing in genomics, data-driven livestock management, and molecular detection technologies aimed at improving productivity and traceability in agriculture and food production. Through businesses such as Neogen Genomics and Geneseek, Neogen has established a significant presence in animal genomics and DNA testing services. Additional investments have targeted manufacturing integration, international commercial expansion, and research capabilities in emerging food safety and biosecurity applications. Public filings and investor materials indicate that operational integration, margin expansion, and cross-selling opportunities remain central strategic priorities.

Geographic Footprint

Neogen is headquartered in Lansing, Michigan, and operates across multiple global regions, including North America, Europe, Asia-Pacific, and Latin America. The company maintains manufacturing, laboratory, distribution, and commercial operations in countries including the United States, the United Kingdom, Ireland, Brazil, China, Mexico, and India. Its international footprint expanded substantially following the integration of the former 3M Food Safety operations.

The company serves customers in more than 100 countries through direct operations, distributors, and channel partners. Neogen’s products are widely used across global food production systems, livestock industries, and laboratory testing environments. Its international presence supports multinational food processors, agricultural producers, and regulatory-driven safety programs, positioning the company as a globally diversified provider within the food and animal safety sectors.

Leadership & Governance

Neogen was founded in 1982 by James Herbert and John Adent, with the company developing under a long-term strategy centered on diagnostics, food safety, and agricultural innovation. The company is led by executive management with experience across diagnostics, manufacturing, animal health, and global operations. Public statements and filings emphasize operational integration, customer-focused innovation, and long-term growth through technology-driven safety solutions.

Key executives include:

• John E. Adent – President and Chief Executive Officer
• David H. Naemura – Chief Financial Officer
• Amy Rocklin – Chief Legal Officer and Corporate Secretary
• James P. Tobin – Vice President of Global Operations
• Jason Lilly – Vice President of Food Safety Commercial Operations

Neogen’s governance structure includes an independent board of directors and oversight practices aligned with U.S. public company standards. Company strategy and governance priorities are discussed in annual reports, proxy statements, and other SEC filings, including the company’s Form 10-K and investor presentations.